TASIGNA Side Effects

7023275-1 | Platelet Count Decreased, Pulmonary Embolism, Transaminases Increased, White Blood Cell Count Decreased
on Sep 27, 2010 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, pulmonary embolism (What is pulmonary embolism?), transaminases increased, white blood cell count decreased. Tasigna dosage: 400 Mg, Bid.

7023134-4 | Acute Myocardial Infarction, Asthenia, Atrial Fibrillation, Chest Discomfort, Chest Pain, Cold Sweat, Diastolic Dysfunction, Disease Progression, Dyspnoea
Patient was taking Tasigna (View Usage). Patient had the following side effects: acute myocardial infarction, asthenia, atrial fibrillation (What is atrial fibrillation?), chest discomfort, chest pain (What is chest pain?), cold sweat, diastolic dysfunction, disease progression, dyspnoea on Sep 24, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , weighting 170.9 lb, was diagnosed with gastrointestinal stromal tumour, hyperlipidaemia, coronary artery disease (What is coronary artery disease?) and. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with IMATINIB (Unk) (View Imatinib Review and Imatinib Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

7023109-5 | Back Pain
Adverse event was reported on Sep 24, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 400 Mg, Unk) was diagnosed with acute myeloid leukaemia and. Location: GERMANY , weighting 119.0 lb, After Tasigna was administered, patient had the following side effects: back pain (What is back pain?). During the same period patient was treated with AFINITOR (2.5 Mg, Unk) (View Afinitor Review and Afinitor Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CONCOR (View Concor Review and Concor Label ). Patient was hospitalized.

7021631-9 | Acute Pulmonary Oedema, Alcohol Poisoning, Confusional State, Disorientation, Hyporeflexia, Metastases To Meninges, Motor Dysfunction, Muscular Weakness, Neuropathy Peripheral
on Sep 29, 2010 Male patient from ITALY , weighting 352.7 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, alcohol poisoning, confusional state, disorientation, hyporeflexia, metastases to meninges, motor dysfunction, muscular weakness, neuropathy peripheral. Tasigna dosage: Unk. During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized and became disabled.


7020713-5 | Anaemia, Febrile Neutropenia, Gastrointestinal Infection, Pneumonia, Pyrexia, Renal Failure
on Sep 23, 2010 Female patient from GERMANY , weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Tasigna (View Usage). Patient had the following side effects: anaemia, febrile neutropenia, gastrointestinal infection, pneumonia (What is pneumonia?), pyrexia, renal failure. Tasigna dosage: 800 Mg, Qd. During the same period patient was treated with AFINITOR (5mg Per Day) (View Afinitor Review and Afinitor Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

7020693-2 | Blast Crisis In Myelogenous Leukaemia, Bone Erosion, Brain Compression, Chloroma, Chronic Myeloid Leukaemia, Pain
Patient was taking Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: blast crisis in myelogenous leukaemia, bone erosion, brain compression, chloroma, chronic myeloid leukaemia, pain (What is pain?) on Sep 22, 2010 from BRAZIL Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with chronic myeloid leukaemia, hypokalaemia, hypocalcaemia and. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with POTASSIUM (View Potassium Review and Potassium Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ).

7016809-4 | Diarrhoea, Malignant Neoplasm Progression
Adverse event was reported on Sep 22, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 400 Mg, Bid) . Location: NETHERLANDS , weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, malignant neoplasm progression. During the same period patient was treated with OXAZEPAM (If Necessary 1 Tablet (10 Mg)) (View Oxazepam Review and Oxazepam Label ), PAROXETINE HCL (10 Mg, Qd) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DOMPERIDONE (1 Tablet (10 Mg), 1-4 Times Daily) (View Domperidone Review and Domperidone Label ).

7014136-2 | Blood Glucose Decreased
on Sep 16, 2010 Male patient from UNITED STATES , weighting 229.3 lb, was diagnosed with neoplasm malignant and was treated with Tasigna (View Usage). Patient had the following side effects: blood glucose decreased. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), VYTORIN (View Vytorin Review and Vytorin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), WARFARIN (View Warfarin Review and Warfarin Label ), IRON (View Iron Review and Iron Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ).

7012883-X | Bronchial Hyperreactivity, Coronary Artery Disease, Drowning, Myocardial Infarction, Obstructive Airways Disorder
on Sep 22, 2010 Female patient from AUSTRIA , 73 years of age, weighting 165.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: bronchial hyperreactivity, coronary artery disease (What is coronary artery disease?), drowning (What is drowning?), myocardial infarction, obstructive airways disorder. Tasigna dosage: 800 Mg Daily. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

7012584-8 | Pulmonary Embolism
Patient was taking Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Sep 23, 2010 from GERMANY Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with chronic myeloid leukaemia and. Tasigna dosage: 400 Mg, Bid.

7009563-3 | Coronary Artery Disease, Drowning, Myocardial Infarction
Adverse event was reported on Sep 20, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 800 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: AUSTRIA , 73 years of age, weighting 165.3 lb, Patient had the following side effects: coronary artery disease (What is coronary artery disease?), drowning (What is drowning?), myocardial infarction.

7009531-1 | Arthralgia, Atelectasis, Chest Pain, Concomitant Disease Progression, Constipation, Diastolic Dysfunction, Dyspnoea, Ejection Fraction Abnormal, Intervertebral Disc Protrusion
on Sep 15, 2010 Male patient from CANADA , weighting 247.4 lb, was diagnosed with chronic myeloid leukaemia, dyspepsia, hypertension, muscle spasms and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: arthralgia, atelectasis, chest pain (What is chest pain?), concomitant disease progression, constipation (What is constipation?), diastolic dysfunction, dyspnoea, ejection fraction abnormal, intervertebral disc protrusion. Tasigna dosage: 300 Mg, Bid. During the same period patient was treated with PANTOLOC (View Pantoloc Review and Pantoloc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NOVASEN (View Novasen Review and Novasen Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

7006684-6 | Neoplasm Malignant, Renal Cancer
on Sep 03, 2010 Male patient from FRANCE , weighting 220.5 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm malignant, renal cancer. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with MERCURY (View Mercury Review and Mercury Label ), SOLVENTS AND DILUT. AGENTS,INCL IRRIGAT SOLUT (View Solvents And Dilut. Agents,incl Irrigat Solut Review and Solvents And Dilut. Agents,incl Irrigat Solut Label ), BYETTA (10 Ug, Bid) (View Byetta Review and Byetta Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), TAREG (1 Df, Qd) (View Tareg Review and Tareg Label ), BISOPROLOL FUMARATE (0.5 Df, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), KARDEGIC (160 Mg Daily) (View Kardegic Review and Kardegic Label ), DIAMICRON (30 Mg, Qd) (View Diamicron Review and Diamicron Label ). Patient was hospitalized.

7006683-4 | Colon Adenoma, Colonic Polyp, Disease Progression, Haematochezia, Haemorrhoids, Large Intestinal Ulcer, Large Intestinal Ulcer Haemorrhage, Melaena, Oesophagitis
Patient was taking Tasigna (View Usage). Patient had the following side effects: colon adenoma, colonic polyp (What is colonic polyp?), disease progression, haematochezia, haemorrhoids, large intestinal ulcer, large intestinal ulcer haemorrhage, melaena, oesophagitis on Jul 28, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with gastrointestinal stromal tumour and. Tasigna dosage: 400 Mg, Bid. Patient was hospitalized.

7005268-3 | Autoimmune Thrombocytopenia, Pancytopenia, Pulmonary Alveolar Haemorrhage, Shock Haemorrhagic
Adverse event was reported on Sep 16, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 2x400 Mg/day) was diagnosed with chromosome analysis abnormal and. Location: GERMANY , weighting 220.5 lb, After Tasigna was administered, patient had the following side effects: autoimmune thrombocytopenia, pancytopenia, pulmonary alveolar haemorrhage, shock haemorrhagic.

6997757-2 | Gastrointestinal Stromal Tumour, Malignant Neoplasm Progression, Metastases To Central Nervous System, Metastases To Liver, Subarachnoid Haemorrhage, Tumour Haemorrhage
on Sep 04, 2010 Male patient from UNITED STATES , 27 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal stromal tumour, malignant neoplasm progression, metastases to central nervous system, metastases to liver, subarachnoid haemorrhage, tumour haemorrhage. Tasigna dosage: . Patient was hospitalized.

6993610-9 | Acute Graft Versus Host Disease In Liver, Blood Creatinine Abnormal, Cytomegalovirus Infection, Klebsiella Sepsis
on Sep 14, 2010 Male patient from AUSTRALIA , weighting 224.9 lb, was diagnosed with chronic myeloid leukaemia, graft versus host disease and was treated with Tasigna (View Usage). Patient had the following side effects: acute graft versus host disease in liver, blood creatinine abnormal, cytomegalovirus infection (What is cytomegalovirus infection?), klebsiella sepsis. Tasigna dosage: 400 Mg Daily. During the same period patient was treated with CYCLOSPORINE (30 Mg, Bid) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (200 Mg, Bid) (View Methylprednisolone Review and Methylprednisolone Label ), URSO FALK (500 Mg, Bid) (View Urso Falk Review and Urso Falk Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ), GENTAMYCIN MP (View Gentamycin-mp Review and Gentamycin-mp Label ), AMBISOME (View Ambisome Review and Ambisome Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FAMVIR (View Famvir Review and Famvir Label ).

6993601-8 | Malignant Neoplasm Progression
Patient was taking Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: malignant neoplasm progression on Sep 16, 2010 from TURKEY Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with gastrointestinal stromal tumour and. Tasigna dosage: 200 Mg Daily.

6985185-5 | Gamma-glutamyltransferase Increased, Malignant Neoplasm Progression, Rash, Tinea Pedis
Adverse event was reported on Sep 01, 2010 by a Male patient taking Tasigna (View Usage) (Dosage: 800 Mg/day) was diagnosed with chronic myeloid leukaemia, benign prostatic hyperplasia, prophylaxis, tinea infection (What is tinea infection?) and. Location: JAPAN , weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: gamma-glutamyltransferase increased, malignant neoplasm progression, rash (What is rash?), tinea pedis. During the same period patient was treated with TAMSULOSIN HCL (0.4mg) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ISODINE (Unk) (View Isodine Review and Isodine Label ), MYCOSYST (100 Mg, Unk) (View Mycosyst Review and Mycosyst Label ).

6985097-7 | Platelet Count Decreased, Sepsis
on Sep 09, 2010 Female patient from UNITED STATES , 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient had the following side effects: platelet count decreased, sepsis (What is sepsis?). Tasigna dosage: 400 Mg, Bid.

6984977-6 | Blast Cell Crisis, Gamma-glutamyltransferase Increased, Rash, Tinea Pedis
on Mar 11, 2010 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with chronic myeloid leukaemia, benign prostatic hyperplasia, prophylaxis, tinea infection (What is tinea infection?) and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: blast cell crisis, gamma-glutamyltransferase increased, rash (What is rash?), tinea pedis. Tasigna dosage: 800 Mg/day. During the same period patient was treated with TAMSULOSIN HCL (0.4mg) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ISODINE (Unk) (View Isodine Review and Isodine Label ), MYCOSYST (100 Mg, Unk) (View Mycosyst Review and Mycosyst Label ).

6981506-8 | Acute Myocardial Infarction, Chest Pain
Patient was taking Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, chest pain (What is chest pain?) on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 186.3 lb, was diagnosed with chronic myeloid leukaemia and. Tasigna dosage: 400 Mg, Qd. Patient was hospitalized.

6981490-7 | Blood Creatinine Increased, Catheterisation Cardiac, Chest Pain, Myocardial Infarction, Stent Placement, Troponin Increased
Adverse event was reported on Sep 01, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 200 Mg, Qd) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , weighting 315.0 lb, Patient had the following side effects: blood creatinine increased, catheterisation cardiac, chest pain (What is chest pain?), myocardial infarction, stent placement, troponin increased. Patient was hospitalized.

6979080-5 | Diabetes Mellitus, Peripheral Arterial Occlusive Disease, Weight Decreased
on Aug 30, 2010 Female patient from AUSTRIA , 69 years of age, weighting 154.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: diabetes mellitus, peripheral arterial occlusive disease, weight decreased. Tasigna dosage: 800 Mg Daily.

6977115-7 | Anaemia, Febrile Neutropenia, Gastrointestinal Infection, Pneumonia, Pyrexia, Renal Failure
on Sep 03, 2010 Female patient from GERMANY , weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, febrile neutropenia, gastrointestinal infection, pneumonia (What is pneumonia?), pyrexia, renal failure. Tasigna dosage: 800 Mg, Qd. During the same period patient was treated with AFINITOR (5mg Per Day) (View Afinitor Review and Afinitor Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), DELIX (View Delix Review and Delix Label ). Patient was hospitalized.

6976753-5 | Blood Calcium Decreased, Blood Creatinine Increased, Blood Urea Increased, Electrocardiogram Qt Prolonged, Hyperuricaemia, Nausea, Oedema, Peritoneal Dialysis, Renal Failure Chronic
Patient was taking Tasigna (View Usage). Patient had the following side effects: blood calcium decreased, blood creatinine increased, blood urea increased, electrocardiogram qt prolonged, hyperuricaemia, nausea (What is nausea?), oedema, peritoneal dialysis, renal failure chronic on Aug 26, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with chronic myeloid leukaemia and. Tasigna dosage: 800 Mg/day. During the same period patient was treated with NAUZELIN (30 Mg, Unk) (View Nauzelin Review and Nauzelin Label ), MENESIT (300 Mg, Unk) (View Menesit Review and Menesit Label ), LASIX (20 Mg, Unk) (View Lasix Review and Lasix Label ), JUSO (1000 Mg, Unk) (View Juso Review and Juso Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), URSO 250 (600 Mg, Unk) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6976751-1 | Acute Myocardial Infarction, Coronary Angioplasty, Coronary Arterial Stent Insertion, Coronary Artery Bypass, Coronary Artery Occlusion
Adverse event was reported on Aug 27, 2010 by a Male patient taking Tasigna (View Usage) (Dosage: 400 Mg Twice Daily) was diagnosed with gastrointestinal stromal tumour and. Location: DENMARK , weighting 176.4 lb, After Tasigna was administered, patient had the following side effects: acute myocardial infarction, coronary angioplasty, coronary arterial stent insertion, coronary artery bypass (What is coronary artery bypass?), coronary artery occlusion. During the same period patient was treated with STREPTASE (View Streptase Review and Streptase Label ).

6974310-8 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Blood Bilirubin Increased, C-reactive Protein Increased, Chest Discomfort, Fluid Retention, Headache, Productive Cough
on Aug 27, 2010 Male patient from FINLAND , 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, blood bilirubin increased, c-reactive protein increased, chest discomfort, fluid retention, headache (What is headache?), productive cough. Tasigna dosage: 400 Mg, Bid. Patient was hospitalized.

6972861-3 | Chromosome Analysis Abnormal, Chronic Myeloid Leukaemia
on Sep 01, 2010 Male patient from BRAZIL , weighting 156.5 lb, was diagnosed with chronic myeloid leukaemia, hypocalcaemia, hypokalaemia and was treated with Tasigna (View Usage). Patient had the following side effects: chromosome analysis abnormal, chronic myeloid leukaemia. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6972327-0 | Angioplasty, Arterial Bypass Operation, Blood Glucose Increased, Intermittent Claudication, Muscle Spasms, Peripheral Arterial Occlusive Disease, Stent Placement
Patient was taking Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: angioplasty (What is angioplasty?), arterial bypass operation, blood glucose increased, intermittent claudication, muscle spasms, peripheral arterial occlusive disease, stent placement on Aug 27, 2010 from AUSTRIA Additional patient health information: Female patient , 68 years of age, was diagnosed with chronic myeloid leukaemia, hypertension, peripheral arterial occlusive disease and. Tasigna dosage: 800 Mg, Qd. During the same period patient was treated with CONCOR (5 Mg, Qd) (View Concor Review and Concor Label ), BLOPRESS (16 Mg, Bid) (View Blopress Review and Blopress Label ), PLAVIX (75 Mg, 1x1) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6969168-7 | Bone Marrow Failure
Adverse event was reported on Aug 25, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 800 Mg Daily) was diagnosed with chronic myeloid leukaemia and. Location: SYRIAN ARAB REPUBLIC , 40 years of age, Patient experienced the following unwanted or unexpected effects: bone marrow failure.

6967182-9 | Therapeutic Response Decreased
on Aug 25, 2010 Male patient from BELGIUM , 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient had the following side effects: therapeutic response decreased. Tasigna dosage: . During the same period patient was treated with SPRYCEL (View Sprycel Review and Sprycel Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6964042-4 | Pancytopenia, Pneumonia
on Sep 02, 2010 Female patient from UNITED STATES , 64 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: pancytopenia, pneumonia (What is pneumonia?). Tasigna dosage: 400 Mg Twice Daily Oral. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), NEUMEGA (View Neumega Review and Neumega Label ). Patient was hospitalized.

6963151-3 | Dermatitis Bullous, Erysipelas, Post Procedural Complication
Patient was taking Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, erysipelas, post procedural complication on Aug 30, 2010 from BRAZIL Additional patient health information: Female patient , weighting 160.9 lb, was diagnosed with gastrointestinal stromal tumour and. Tasigna dosage: 800 Mg, Qd. Patient was hospitalized.

6961426-5 | Dermatitis Bullous, Erysipelas, Post Procedural Complication
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tasigna (View Usage) (Dosage: 800 Mg, Qd) was diagnosed with gastrointestinal stromal tumour and. Location: BRAZIL , weighting 160.9 lb, Patient had the following side effects: dermatitis bullous, erysipelas, post procedural complication. Patient was hospitalized.

6958704-2 | Conjunctivitis, Face Oedema, Headache, Pruritus, Rash, Skin Lesion
on Aug 17, 2010 Male patient from FRANCE , weighting 176.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: conjunctivitis, face oedema, headache (What is headache?), pruritus, rash (What is rash?), skin lesion. Tasigna dosage: 800 Mg.

6956150-9 | Abdominal Pain Upper, Helicobacter Gastritis, Nausea
on Aug 15, 2010 Female patient from SAUDI ARABIA , 60 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, helicobacter gastritis, nausea (What is nausea?). Tasigna dosage: 2 Pills 200mg. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6945923-4 | Alcohol Poisoning, Confusional State, Disorientation, Hyporeflexia, Metastases To Meninges, Motor Dysfunction, Muscular Weakness, Neuropathy Peripheral
Patient was taking Tasigna (View Usage). Patient had the following side effects: alcohol poisoning, confusional state, disorientation, hyporeflexia, metastases to meninges, motor dysfunction, muscular weakness, neuropathy peripheral on Aug 24, 2010 from ITALY Additional patient health information: Male patient , weighting 352.7 lb, was diagnosed with chronic myeloid leukaemia and. Tasigna dosage: Unk. During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized and became disabled.

6939343-6 | Alcohol Poisoning, Confusional State, Disorientation, Hyporeflexia, Metastases To Meninges, Motor Dysfunction, Muscular Weakness, Neuropathy Peripheral
Adverse event was reported on Aug 12, 2010 by a Male patient taking Tasigna (View Usage) (Dosage: Unk) was diagnosed with chronic myeloid leukaemia and. Location: ITALY , weighting 352.7 lb, After Tasigna was administered, patient had the following side effects: alcohol poisoning, confusional state, disorientation, hyporeflexia, metastases to meninges, motor dysfunction, muscular weakness, neuropathy peripheral. During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized and became disabled.

6935310-7 | Granulocytopenia, Leukopenia, Thrombocytopenia
on Aug 03, 2010 Female patient from UKRAINE , 49 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, leukopenia, thrombocytopenia. Tasigna dosage: 600 Mg Daily. Patient was hospitalized.

6935215-1 |
on Aug 18, 2010 Male patient from JAPAN , weighting 92.59 lb, was diagnosed with chronic myeloid leukaemia, constipation (What is constipation?), otitis media chronic, prophylaxis and was treated with Tasigna (View Usage). . Tasigna dosage: 800 Mg Daily. During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), BACTROBAN (Unk) (View Bactroban Review and Bactroban Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6935213-8 | Graft Versus Host Disease, Klebsiella Sepsis
Patient was taking Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: graft versus host disease, klebsiella sepsis on Aug 17, 2010 from AUSTRALIA Additional patient health information: Male patient , weighting 224.9 lb, was diagnosed with chronic myeloid leukaemia, graft versus host disease and. Tasigna dosage: 400 Mg Daily. During the same period patient was treated with CYCLOSPORINE (30 Mg, Bid) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (200 Mg, Bid) (View Methylprednisolone Review and Methylprednisolone Label ), URSO FALK (500 Mg, Bid) (View Urso Falk Review and Urso Falk Label ), ATG /BEL/ (View Atg /bel/ Review and Atg /bel/ Label ), GENTAMYCIN MP (View Gentamycin-mp Review and Gentamycin-mp Label ), AMBISOME (View Ambisome Review and Ambisome Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FAMVIR (View Famvir Review and Famvir Label ).

6935049-8 | Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Colitis, Diarrhoea, Gamma-glutamyltransferase Increased, Pyrexia
Adverse event was reported on Aug 11, 2010 by a Male patient taking Tasigna (View Usage) (Dosage: 200 Mg/ Day) was diagnosed with acute myeloid leukaemia and. Location: GERMANY , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, c-reactive protein increased, colitis, diarrhoea, gamma-glutamyltransferase increased, pyrexia. During the same period patient was treated with AFINITOR (2.5 Mg) (View Afinitor Review and Afinitor Label ), REKAWAN (Unk) (View Rekawan Review and Rekawan Label ). Patient was hospitalized.

6921503-1 | Electrocardiogram Qt Prolonged, Hypokalaemia, Pain, Platelet Count Increased, Rash
on Aug 05, 2010 Female patient from UNITED STATES , weighting 258.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, hypokalaemia, pain (What is pain?), platelet count increased, rash (What is rash?). Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), POTASSIUM (View Potassium Review and Potassium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

6916465-7 | Abdominal Discomfort, Fatigue, Incorrect Dose Administered, Treatment Noncompliance
on Jul 28, 2010 Female patient from UNITED STATES , weighting 162.8 lb, was diagnosed with chronic myeloid leukaemia, sleep disorder (What is sleep disorder?), arthralgia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: abdominal discomfort, fatigue, incorrect dose administered, treatment noncompliance. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with AMBIEN (5 Mg) (View Ambien Review and Ambien Label ), IBUPROFEN (ADVIL) (200 Mg) (View Ibuprofen (advil) Review and Ibuprofen (advil) Label ).

6909341-7 | Anaemia, Tachycardia, Tumour Haemorrhage, Venous Haemorrhage
Patient was taking Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, tachycardia, tumour haemorrhage, venous haemorrhage on Jul 29, 2010 from FRANCE Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with gastrointestinal stromal tumour and. Tasigna dosage: 400 Mg, Bid. Patient was hospitalized.

6907888-0 | Aphasia, Hallucination, Auditory, Hallucination, Visual
Adverse event was reported on Jul 22, 2010 by a Male patient taking Tasigna (View Usage) (Dosage: 800 Mg Daily) was diagnosed with chronic myeloid leukaemia, pain (What is pain?) and. Location: ISRAEL , 63 years of age, Patient had the following side effects: aphasia (What is aphasia?), hallucination, auditory, hallucination, visual. During the same period patient was treated with CANNABIS (View Cannabis Review and Cannabis Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), DISOTHIAZIDE (View Disothiazide Review and Disothiazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6906197-3 | Cardiac Failure, Myocardial Infarction
on Jul 23, 2010 Female patient from AUSTRIA , 81 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). After Tasigna was administered, patient had the following side effects: cardiac failure, myocardial infarction. Tasigna dosage: 800 Mg Daily.

6900383-4 | Angina Pectoris, Chest Pain
on Jul 27, 2010 Female patient from CANADA , weighting 119.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Tasigna (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, chest pain (What is chest pain?). Tasigna dosage: 400 Mg. Patient was hospitalized.

6900366-4 | Decreased Appetite, Swelling, Weight Decreased
Patient was taking Tasigna (View Usage). Patient had the following side effects: decreased appetite, swelling, weight decreased on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, was diagnosed with leukaemia and. Tasigna dosage: 400 Mg, Bid. During the same period patient was treated with PHENERGAN (Unk) (View Phenergan Review and Phenergan Label ), TYLENOL (Unk) (View Tylenol Review and Tylenol Label ), ZOFRAN (Unk) (View Zofran Review and Zofran Label ), MECLIZINE (Unk) (View Meclizine Review and Meclizine Label ), TRAZODONE (Unk) (View Trazodone Review and Trazodone Label ).